Helsinki-based MVision developed AI software focusing on radiation treatment planning. Clinical use of the software was deployed in two Finnish…

More than 1 million men are diagnosed with prostate cancer worldwide each year. If the prostate cancer has not yet…

Jani Mikkola (M.Sc., Econ.; B.Sc., Soc. Sc.) has been appointed as Commercial Director of Docrates Cancer Center as of 21…

Radiation therapy is an extremely effective treatment method in prostate cancer. The survival rate for patients undergoing radiation therapy for…

The long-term follow-up results of interstitial HDR brachytherapy in prostate cancer treatment seem very promising. The results were presented at…

PRESS RELEASE 9 January 2017 Prostate cancer is the most common type of cancer globally. The risk of developing the…

PRESS RELEASE 3.10.2016 Docrates joins Cancer Experts Now, an international network of cancer specialists Docrates Cancer Center and Cancer Expert…

For the first time in Finland, Docrates Cancer Center will adopt a sophisticated test for diagnosing prostate cancer Docrates Cancer…

Tatiana Heinonen and Svetlana Maganova are sisters born in Moscow. Along their life, they have been re-evaluating their attitude to…

Docrates Cancer Center and GenoMill Health, a Finnish health technology company, bring a new Color gene risk test available for…